LeonaBio, Inc. (LONA) reporting calendar
LeonaBio, Inc. files periodic reports with the SEC as LONA on Nasdaq. Atlas tracks 23 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 9 Jul 2026 – 5 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 23
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open LONA market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-211898 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001193125-26-134565 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001193125-25-269544 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0000950170-25-105052 |
| 10-Q | 31 Mar 2025 | 9 May 2025 | 39 days | 0000950170-25-068040 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0000950170-25-029069 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-123372 |
| 10-Q | 30 Jun 2024 | 1 Aug 2024 | 32 days | 0000950170-24-089304 |
| 10-Q | 31 Mar 2024 | 15 May 2024 | 45 days | 0000950170-24-060482 |
| 10-K | 31 Dec 2023 | 22 Feb 2024 | 53 days | 0000950170-24-018787 |
| 10-Q | 30 Sep 2023 | 9 Nov 2023 | 40 days | 0000950170-23-062082 |
| 10-Q | 30 Jun 2023 | 10 Aug 2023 | 41 days | 0000950170-23-041346 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0000950170-23-021274 |
| 10-K | 31 Dec 2022 | 23 Mar 2023 | 82 days | 0000950170-23-009498 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0000950170-22-024499 |
| 10-Q | 30 Jun 2022 | 15 Aug 2022 | 46 days | 0000950170-22-017421 |
| 10-Q | 31 Mar 2022 | 12 May 2022 | 42 days | 0000950170-22-009683 |
| 10-K | 31 Dec 2021 | 28 Mar 2022 | 87 days | 0000950170-22-004782 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0000950170-21-004091 |
| 10-Q | 30 Jun 2021 | 16 Aug 2021 | 47 days | 0001564590-21-044641 |
| 10-Q | 31 Mar 2021 | 13 May 2021 | 43 days | 0001564590-21-027607 |
| 10-K | 31 Dec 2020 | 25 Mar 2021 | 84 days | 0001564590-21-015495 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001564590-20-053574 |
Source: SEC EDGAR company submissions for CIK 0001620463. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.